Dr. Janet Woodcock, director of the FDA’s Center for Drug Evaluation and
Research, testified at a hearing on improving the approval process for
generic drugs to make them more accessible.
After the hearing adjourned, Dr. Woodcock spoke to reporters.
Click here for video.
Source: C-Span
No comments:
Post a Comment